GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Biogen BIIB · USD

Health Care · Biotechnology · US listing · 🇺🇸 United States

S&P 500

Compare

254.87

+2.63%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Biogen

Our reporting

Next results

5 Feb 2027

Due on 5 Feb 2027. Analysts expect earnings of 2.85 a share on revenue of $2.61bn.

Past results

Reported against what analysts expected

28 Oct 202629 Jul 202629 Apr 20266 Feb 202630 Oct 202531 Jul 2025
Earnings per share2.623.603.571.994.815.47
Forecast1.992.943.051.633.883.90
Revenue$2.80bn$2.74bn$2.48bn$2.28bn$2.45bn$2.65bn
Forecast$2.63bn$2.46bn$2.29bn$2.20bn$2.34bn$2.33bn

Key events

  1. 18 Jan 20013-for-1 share split
  2. 21 Dec 19992-for-1 share split
  3. 17 Sept 1991Listed

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.